Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 3 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 27, 2021 Filed May 28, 2021 20:01 UTC |
BARBIER REMIDirector · President and CEO
|
Exercise / conversionCommon Stock | 56,030 | $53.55 | $3,000,406.50 |
DisclosureSEC source: 0001069530-21-000031 · certent-form4.xml · nonDerivative · entry 1 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,134,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 01:14 UTC |
ROBERTSON SANFORDDirector
|
Exercise / conversionCommon Stock · Derivative | 4,670 | $49.00 Strike: $49.00 | $228,830.00 |
DisclosureSEC source: 0001069530-21-000024 · certent-form4.xml · derivative · entry 4 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,670 shares Expires 2021-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 01:14 UTC |
ROBERTSON SANFORDDirector
|
Exercise / conversionCommon Stock · Derivative | 2,802 | $27.37 Strike: $27.37 | $76,690.74 |
DisclosureSEC source: 0001069530-21-000024 · certent-form4.xml · derivative · entry 3 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,802 shares Expires 2021-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 01:14 UTC |
ROBERTSON SANFORDDirector
|
Exercise / conversionCommon Stock | 4,670 | $49.00 | $228,830.00 |
DisclosureSEC source: 0001069530-21-000024 · certent-form4.xml · nonDerivative · entry 2 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 01:14 UTC |
ROBERTSON SANFORDDirector
|
Exercise / conversionCommon Stock | 2,802 | $27.37 | $76,690.74 |
DisclosureSEC source: 0001069530-21-000024 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 915,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2021 Filed Feb 3, 2022 22:11 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
GiftCommon Stock | 1,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001069530-22-000007 · certent-form5.xml · nonDerivative · entry 1 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,089 F1 · price: Bona Fide Gift Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 20:06 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock · Derivative | 28,015 | $53.55 Strike: $53.55 | $1,500,203.25 |
DisclosureSEC source: 0001069530-21-000016 · certent-form4.xml · derivative · entry 3 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,015 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 20:06 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
Tax withholdingCommon Stock | 23,996 | $62.52 | $1,500,229.92 |
DisclosureSEC source: 0001069530-21-000016 · certent-form4.xml · nonDerivative · entry 2 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,429 F1 · balance_after: Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 20:06 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock | 28,015 | $53.55 | $1,500,203.25 |
DisclosureSEC source: 0001069530-21-000016 · certent-form4.xml · nonDerivative · entry 1 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 19:59 UTC |
O DONNELL MICHAEL JDirector
|
Exercise / conversionCommon Stock · Derivative | 4,669 | $49.00 Strike: $49.00 | $228,781.00 |
DisclosureSEC source: 0001069530-21-000013 · certent-form4.xml · derivative · entry 3 O DONNELL MICHAEL J · CIK 0001245266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,669 shares Expires 2021-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 19:59 UTC |
O DONNELL MICHAEL JDirector
|
Tax withholdingCommon Stock | 4,387 | $52.16 | $228,825.92 |
DisclosureSEC source: 0001069530-21-000013 · certent-form4.xml · nonDerivative · entry 2 O DONNELL MICHAEL J · CIK 0001245266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,870 F1 · balance_after: Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 19:59 UTC |
O DONNELL MICHAEL JDirector
|
Exercise / conversionCommon Stock | 4,669 | $49.00 | $228,781.00 |
DisclosureSEC source: 0001069530-21-000013 · certent-form4.xml · nonDerivative · entry 1 O DONNELL MICHAEL J · CIK 0001245266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 22:08 UTC |
SCANNON PATRICK J MD PHDDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $8.12 | $0.00 |
DisclosureSEC source: 0001069530-20-000077 · certent-form4.xml · derivative · entry 1 SCANNON PATRICK J MD PHD · CIK 0001222790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-12-11 F1 · derivative.exercise_date: Stock Options issued pursuant to the Company's Equity Incentive Plan vest over four (4) years at a rate of 1/48th each month. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 22:06 UTC |
GUSSIN ROBERT ZDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $8.12 | $0.00 |
DisclosureSEC source: 0001069530-20-000075 · certent-form4.xml · derivative · entry 1 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-12-11 F1 · derivative.exercise_date: Stock Options issued pursuant to the Company's Equity Incentive Plan vest over four (4) years at a rate of 1/48th each month. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 22:04 UTC |
ROBERTSON SANFORDDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $8.12 | $0.00 |
DisclosureSEC source: 0001069530-20-000073 · certent-form4.xml · derivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-12-11 F1 · derivative.exercise_date: Stock Options issued pursuant to the Company's Equity Incentive Plan vest over four (4) years at a rate of 1/48th each month. Read SEC document |
| September 24, 2020 Filed Sep 24, 2020 20:49 UTC |
BARBIER REMIDirector · President and CEO
|
PurchaseCommon Stock | 10,000 | $9.59 | $95,900.00 |
DisclosureSEC source: 0001069530-20-000062 · certent-form4.xml · nonDerivative · entry 1 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078,855 F1 · price: The purchase price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $9.48 to $9.67 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| September 18, 2020 Filed Sep 21, 2020 20:01 UTC |
ROBERTSON SANFORDDirector
|
PurchaseCommon Stock | 36,281 | $8.92 | $323,626.52 |
DisclosureSEC source: 0001069530-20-000059 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 912,623 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.75 to $9.04 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| September 17, 2020 Filed Sep 17, 2020 21:25 UTC |
Schoen EricChief Financial Officer
|
PurchaseCommon Stock | 2,000 | $7.04 | $14,080.00 |
DisclosureSEC source: 0001069530-20-000057 · certent-form4.xml · nonDerivative · entry 2 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Purchase by Schoen Family LLC. Reporting person is a member of the Schoen Family LLC. Disclosed balance after: 27,300 Read SEC document |
| September 17, 2020 Filed Sep 17, 2020 21:25 UTC |
Schoen EricChief Financial Officer
|
PurchaseCommon Stock | 10,000 | $7.03 | $70,300.00 |
DisclosureSEC source: 0001069530-20-000057 · certent-form4.xml · nonDerivative · entry 1 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,300 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $7.01 to $7.04 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| September 17, 2020 Filed Sep 17, 2020 21:15 UTC |
ROBERTSON SANFORDDirector
|
PurchaseCommon Stock | 213,719 | $6.98 | $1,491,758.62 |
DisclosureSEC source: 0001069530-20-000055 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 876,342 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.77 to $7.20 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| December 31, 2019 Filed Dec 31, 2019 21:10 UTC |
BARBIER REMIDirector · President and CEO
|
PurchaseCommon Stock | 100,000 | $5.53 | $553,000.00 |
DisclosureSEC source: 0001069530-19-000074 · certent-form4.xml · nonDerivative · entry 1 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,068,855 F1 · balance_after: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.34 to $5.70 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| December 26, 2019 Filed Dec 26, 2019 21:03 UTC |
BARBIER REMIDirector · President and CEO
|
PurchaseCommon Stock | 10,000 | $4.15 | $41,500.00 |
DisclosureSEC source: 0001069530-19-000072 · certent-form4.xml · nonDerivative · entry 1 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Purchase by spouse of reporting person Disclosed balance after: 968,855 Read SEC document |
| December 20, 2019 Filed Dec 20, 2019 21:11 UTC |
ROBERTSON SANFORDDirector
|
PurchaseCommon Stock | 423,788 | $2.20 | $932,333.60 |
DisclosureSEC source: 0001069530-19-000065 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 662,623 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.09 to $2.26 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| December 19, 2019 Filed Dec 19, 2019 23:06 UTC |
Schoen EricChief Financial Officer
|
PurchaseCommon Stock | 5,300 | $1.88 | $9,964.00 |
DisclosureSEC source: 0001069530-19-000063 · certent-form4.xml · nonDerivative · entry 1 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,300 Read SEC document |
| December 19, 2019 Filed Dec 19, 2019 23:04 UTC |
ROBERTSON SANFORDDirector
|
PurchaseCommon Stock | 76,212 | $1.86 | $141,754.32 |
DisclosureSEC source: 0001069530-19-000061 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,835 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.68 to $1.94 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:13 UTC |
BARBIER REMIDirector · President and CEO
|
PurchaseCommon Stock | 2,599 | $1.65 | $4,288.35 |
DisclosureSEC source: 0001069530-19-000068 · certent-form4.xml · nonDerivative · entry 1 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Purchase by spouse of reporting person Disclosed balance after: 2,599 Read SEC document |
| December 18, 2019 Filed Dec 26, 2019 21:00 UTC Amendment |
BARBIER REMIDirector · President and CEO
|
PurchaseCommon Stock | 2,599 | $1.65 | $4,288.35 |
DisclosureSEC source: 0001069530-19-000070 · certent-form4a.xml · nonDerivative · entry 1 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Purchase by spouse of reporting person Disclosed balance after: 958,855 F1 · balance_after: In a Form 4 filed on December 20, 2019 (the "Form 4"), the reporting person reported 2,599 shares as the "Amount of Securities Beneficially Owned Following Reported Transaction." This amendment to the Form 4 is being filed to reflect 958,855 as the correct number of shares of stock beneficially owned by the reporting person following the reported transaction. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 20:57 UTC |
FRIEDMANN NADAVDirector · Chief Medical & Operating Off.
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001069530-19-000049 · certent-form4.xml · derivative · entry 1 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical & Operating Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-12-13 F1 · derivative.exercise_date: Stock Options issued pursuant to the Company's Equity Incentive Plan vest over four (4) years at a rate of 1/48th each month. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 20:59 UTC |
O DONNELL MICHAEL JDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001069530-19-000051 · certent-form4.xml · derivative · entry 1 O DONNELL MICHAEL J · CIK 0001245266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-12-13 F1 · derivative.exercise_date: Stock Options issued pursuant to the Company's Equity Incentive Plan vest over four (4) years at a rate of 1/48th each month. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 20:55 UTC |
BARBIER REMIDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001069530-19-000047 · certent-form4.xml · derivative · entry 1 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-12-13 F1 · derivative.exercise_date: Stock Options issued pursuant to the Company's Equity Incentive Plan vest over four (4) years at a rate of 1/48th each month. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 21:06 UTC |
GUSSIN ROBERT ZDirector
|
GrantStock option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001069530-19-000059 · certent-form4.xml · derivative · entry 1 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-12-13 F1 · derivative.exercise_date: Stock Options issued pursuant to the Company's Equity Incentive Plan vest over four (4) years at a rate of 1/48th each month. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 21:02 UTC |
ROBERTSON SANFORDDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001069530-19-000055 · certent-form4.xml · derivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-12-13 F1 · derivative.exercise_date: Stock Options issued pursuant to the Company's Equity Incentive Plan vest over four (4) years at a rate of 1/48th each month. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 21:03 UTC |
SCANNON PATRICK J MD PHDDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001069530-19-000057 · certent-form4.xml · derivative · entry 1 SCANNON PATRICK J MD PHD · CIK 0001222790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-12-13 F1 · derivative.exercise_date: Stock Options issued pursuant to the Company's Equity Incentive Plan vest over four (4) years at a rate of 1/48th each month. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 21:00 UTC |
Ramasastry SairaDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001069530-19-000053 · certent-form4.xml · derivative · entry 1 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-12-13 F1 · derivative.exercise_date: Stock Options issued pursuant to the Company's Equity Incentive Plan vest over four (4) years at a rate of 1/48th each month. Read SEC document |
| May 14, 2019 Filed May 15, 2019 21:50 UTC |
Schoen EricChief Financial Officer
|
PurchaseCommon Stock | 10,000 | $1.06 | $10,600.00 |
DisclosureSEC source: 0001069530-19-000030 · certent-form4.xml · nonDerivative · entry 1 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.05 to $1.06 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 20:32 UTC |
Schoen EricChief Financial Officer
|
GrantCommon Stock (1) · Derivative | 50,000 | $1.18 Strike: $1.18 | $59,000.00 |
DisclosureSEC source: 0001069530-18-000062 · primary_doc.xml · derivative · entry 1 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-10-31 Read SEC document |
| October 03, 2018 Filed Oct 5, 2018 21:58 UTC |
ARMISTICE CAPITAL, LLC10% owner
Armistice Capital Master Fund Ltd.10% owner
Boyd Steven10% owner
|
SaleCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-18-006525 · ownership.xml · nonDerivative · entry 3 ARMISTICE CAPITAL, LLC · CIK 0001601086 · 10% owner Armistice Capital Master Fund Ltd. · CIK 0001633584 · 10% owner Boyd Steven · CIK 0001706140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F2 · ownership.nature: The reported securities are directly owned by Armistice Capital Master Fund Ltd., a Cayman Islands corporation, and may be deemed to be indirectly beneficially owned by Armistice Capital, LLC, as the investment manager of Armistice Capital Master Fund Ltd. The reported securities may also be deemed to be indirectly beneficially owned by Steven Boyd as Managing Member of Armistice Capital, LLC and Director of Armistice Capital Master Fund Ltd. Armistice Capital, LLC and Steven Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| October 03, 2018 Filed Oct 5, 2018 21:58 UTC |
ARMISTICE CAPITAL, LLC10% owner
Armistice Capital Master Fund Ltd.10% owner
Boyd Steven10% owner
|
SaleCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-18-006525 · ownership.xml · nonDerivative · entry 2 ARMISTICE CAPITAL, LLC · CIK 0001601086 · 10% owner Armistice Capital Master Fund Ltd. · CIK 0001633584 · 10% owner Boyd Steven · CIK 0001706140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F2 · ownership.nature: The reported securities are directly owned by Armistice Capital Master Fund Ltd., a Cayman Islands corporation, and may be deemed to be indirectly beneficially owned by Armistice Capital, LLC, as the investment manager of Armistice Capital Master Fund Ltd. The reported securities may also be deemed to be indirectly beneficially owned by Steven Boyd as Managing Member of Armistice Capital, LLC and Director of Armistice Capital Master Fund Ltd. Armistice Capital, LLC and Steven Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| October 03, 2018 Filed Oct 5, 2018 21:58 UTC |
ARMISTICE CAPITAL, LLC10% owner
Armistice Capital Master Fund Ltd.10% owner
Boyd Steven10% owner
|
SaleCommon Stock | 512,660 | $1.31 | $671,738.40 |
DisclosureSEC source: 0000919574-18-006525 · ownership.xml · nonDerivative · entry 1 ARMISTICE CAPITAL, LLC · CIK 0001601086 · 10% owner Armistice Capital Master Fund Ltd. · CIK 0001633584 · 10% owner Boyd Steven · CIK 0001706140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,651,340 F3 · price: This constitutes the weighted average sale price. The prices range from $1.2386 to $1.3671. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.direct: The reported securities are directly owned by Armistice Capital Master Fund Ltd. Read SEC document |
| September 28, 2018 Filed Oct 9, 2018 21:50 UTC |
BARBIER REMIDirector · CEO, Chairman of the Board · 10% owner
|
GrantStock Options(1) · Derivative | 60,000 | $1.01 Strike: $1.01 | $60,600.00 |
DisclosureSEC source: 0001069530-18-000056 · primary_doc.xml · derivative · entry 1 BARBIER REMI · CIK 0001133806 · Director · CEO, Chairman of the Board · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2028-09-28 Read SEC document |
| September 27, 2018 Filed Sep 27, 2018 20:41 UTC |
ROBERTSON SANFORDDirector
|
PurchaseCommon Stock | 37,817 | $1.05 | $39,707.85 |
DisclosureSEC source: 0001069530-18-000053 · primary_doc.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,623 Read SEC document |
| September 26, 2018 Filed Sep 26, 2018 21:52 UTC |
ROBERTSON SANFORDDirector
|
PurchaseCommon Stock | 30,992 | $1.05 | $32,541.60 |
DisclosureSEC source: 0001069530-18-000052 · primary_doc.xml · nonDerivative · entry 3 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,806 Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 21:52 UTC |
ROBERTSON SANFORDDirector
|
PurchaseCommon Stock | 21,420 | $1.00 | $21,420.00 |
DisclosureSEC source: 0001069530-18-000052 · primary_doc.xml · nonDerivative · entry 2 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,814 Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 21:52 UTC |
ROBERTSON SANFORDDirector
|
PurchaseCommon Stock | 9,771 | $0.96 | $9,380.16 |
DisclosureSEC source: 0001069530-18-000052 · primary_doc.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,394 Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 23:26 UTC |
GUSSIN ROBERT ZDirector
|
GrantStock Options(1) · Derivative | 15,000 | $0.95 Strike: $0.95 | $14,250.00 |
DisclosureSEC source: 0001069530-18-000051 · primary_doc.xml · derivative · entry 1 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,468 Underlying: Common Stock · 15,000 shares Expires 2028-09-14 Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 23:21 UTC |
O DONNELL MICHAEL JDirector
|
GrantStock Options(1) · Derivative | 10,000 | $0.95 Strike: $0.95 | $9,500.00 |
DisclosureSEC source: 0001069530-18-000050 · primary_doc.xml · derivative · entry 1 O DONNELL MICHAEL J · CIK 0001245266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,446 Underlying: Common Stock · 10,000 shares Expires 2028-09-14 Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 23:08 UTC |
Ramasastry SairaDirector
|
GrantStock Options(1) · Derivative | 15,000 | $0.95 Strike: $0.95 | $14,250.00 |
DisclosureSEC source: 0001069530-18-000049 · primary_doc.xml · derivative · entry 1 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,991 Underlying: Common Stock · 15,000 shares Expires 2028-09-14 Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 23:00 UTC |
ROBERTSON SANFORDDirector
|
GrantStock Options(1) · Derivative | 15,000 | $0.95 Strike: $0.95 | $14,250.00 |
DisclosureSEC source: 0001069530-18-000048 · primary_doc.xml · derivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,472 Underlying: Common Stock · 15,000 shares Expires 2028-09-14 Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:38 UTC |
SCANNON PATRICK J MD PHDDirector
|
GrantStock Options(1) · Derivative | 10,000 | $0.95 Strike: $0.95 | $9,500.00 |
DisclosureSEC source: 0001069530-18-000047 · primary_doc.xml · derivative · entry 1 SCANNON PATRICK J MD PHD · CIK 0001222790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,400 Underlying: Common Stock · 10,000 shares Expires 2028-09-14 Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:26 UTC |
FRIEDMANN NADAVDirector · Chief Sientific Officer
|
GrantStock Options(1) · Derivative | 50,000 | $0.95 Strike: $0.95 | $47,500.00 |
DisclosureSEC source: 0001069530-18-000046 · primary_doc.xml · derivative · entry 1 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Sientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,993 Underlying: Common Stock · 50,000 shares Expires 2028-09-14 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.